Brevan Howard Capital Management LP Tarsus Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 43,380 shares of TARS stock, worth $2.36 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,380Holding current value
$2.36 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$186 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$178 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$133 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$123 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$120 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.45B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...